<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03411642</url>
  </required_header>
  <id_info>
    <org_study_id>PV5225</org_study_id>
    <nct_id>NCT03411642</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke</brief_title>
  <acronym>CONTEST</acronym>
  <official_title>Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Albertinen-Krankenhaus Hamburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regio Klinikum Pinneberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helios Universitätsklinikum Wuppertal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kreiskliniken Reutlingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Karlsbad-Langensteinbach</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in
      Stroke (CONTEST) aims at assessing the diagnostic value of transesophageal echocardiography
      (TEE) and transthoracic echocardiography (TTE) with regards to treatment consequences in
      patients with acute ischemic stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For this purpose, the investigators will perform a prospective multicenter diagnostic
      comparative effectiveness study. Patients with acute stroke will be studied by both TTE and
      TEE. Patients with already defined stroke etiology and determined secondary prevention will
      be excluded from the trial. Treatment relevant diagnostic findings will be identified by a
      central endpoint adjudication committee. In order to demonstrate a hypothesized 2% absolute
      increase in the number of treatment relevant diagnostic findings by TEE as compared to TTE,
      880 stroke patients will be enrolled in six German stroke centers. CONTEST will allow
      answering the question whether and for which group of stroke patients TEE is indicated in
      addition to TTE. By this, the study will provide evidence to guide justified recommendations
      for echocardiography in acute stroke patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of diagnostic findings that lead to a change in acute treatment or treatment for secondary prevention</measure>
    <time_frame>Baseline</time_frame>
    <description>Treatment relevant diagnostic findings will be identified by a central endpoint adjudication committee comprising both cardiologists and neurologists.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of other major or minor risk factors for cardiac embolism detected by TTE or TEE.</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">880</enrollment>
  <condition>Stroke, Acute</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute stroke in whom echocardiography is indicated will be studied by TTE and
        TEE.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute ischemic stroke or transitory ischemic attack (TIA)

          -  age ≥18 years

          -  informed consent

        Exclusion Criteria:

          -  Patients with already defined stroke etiology and determined secondary prevention
             treatment strategy prior to echocardiography (e.g. atrial fibrillation, carotid artery
             stenosis, cervical artery dissection)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Götz Thomalla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Götz Thomalla, MD</last_name>
    <phone>004940741050137</phone>
    <email>thomalla@uke.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>SRH Klinikum Karlsbad-Langensteinbach</name>
      <address>
        <city>Karlsbad</city>
        <state>Baden-Württemberg</state>
        <zip>76307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Fetter, MD</last_name>
      <phone>00497202613606</phone>
      <email>neurologie.kkl@srh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Götz Thomalla, MD</last_name>
      <phone>004940741050137</phone>
      <email>thomalla@uke.de</email>
    </contact>
    <investigator>
      <last_name>Renate Schnabel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Götz Thomalla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albertinen-Krankenhaus</name>
      <address>
        <city>Hamburg</city>
        <zip>22457</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Rosenkranz, MD</last_name>
      <phone>00494055882215</phone>
      <email>Michael.Rosenkranz@albertinen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regio Klinikum Pinneberg</name>
      <address>
        <city>Pinneberg</city>
        <zip>25421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Max Nedelmann, MD</last_name>
      <phone>00494101217961</phone>
      <email>max.nedelmann@sana.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kreiskliniken Reutlingen</name>
      <address>
        <city>Reutlingen</city>
        <zip>72764</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frank Andres, MD</last_name>
      <email>andres_f@kreiskliniken-reutlingen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2018</study_first_submitted>
  <study_first_submitted_qc>January 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2018</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke, echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

